EYS606
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for EYS606, covering 2022-03-10 to 2022-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU) [Phase 2]